GO:0051620 norepinephrine uptake: Synaptic Reuptake Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0051620 (norepinephrine uptake) describes the directed movement of norepinephrine into a cell, typically presynaptic neurons or glial cells, as defined by QuickGO.
• Norepinephrine is a hormone secreted by the adrenal medulla and a neurotransmitter in the sympathetic peripheral nervous system and some CNS tracts, and it is the biosynthetic precursor of epinephrine.
• High-affinity noradrenaline uptake occurs not only in presynaptic neurons but also in postsynaptic neurones, as demonstrated in rat brain preparations.
• Norepinephrine uptake can be modulated by pharmacological agents including halothane, cyclic AMP-elevating agents, soman, methadone, and triple uptake inhibitors.
• Dysregulation of norepinephrine uptake is implicated in depression and other psychiatric disorders, making it a target for antidepressant drug development.
• Studying norepinephrine uptake requires models such as synaptosomes, tissue slices, and cell lines, combined with radiolabeled norepinephrine and CRISPR-based gene editing.
Description
Norepinephrine (also called noradrenaline) is a catecholamine hormone and neurotransmitter that is secreted by the adrenal medulla and acts in the sympathetic peripheral nervous system and in some tracts of the central nervous system [QuickGO]. The process by which norepinephrine is moved into cells, termed norepinephrine uptake (GO:0051620), is a critical biological process that terminates its synaptic action and regulates its availability for reuse. This process is typically mediated by presynaptic neurons or glial cells, and it is essential for normal neurotransmission and hormonal balance. Research has shown that norepinephrine uptake can be studied in various tissues, including canine saphenous veins, rat cerebral cortex slices, and human uterine arteries. The uptake mechanism is not limited to presynaptic sites; high-affinity uptake has also been observed in postsynaptic neurones, indicating a broader role in norepinephrine clearance and signaling modulation. Pharmacological modulation of norepinephrine uptake is of significant clinical interest. For instance, noradrenaline reuptake inhibition is a key mechanism in antidepressant action, and predicting response to such treatments is an active area of research. Triple uptake inhibitors, which block the reuptake of serotonin, norepinephrine, and dopamine, have therapeutic potential in depression and beyond. Additionally, agents that increase cyclic AMP levels can affect norepinephrine uptake and release in brain slices, and compounds like methadone can inhibit uptake in vitro. These findings underscore the importance of understanding the molecular and cellular mechanisms of norepinephrine uptake for both basic neuroscience and drug development.
norepinephrine uptake At A Glance
| GO ID | GO:0051620 |
|---|---|
| GO term | norepinephrine uptake |
| Ontology | biological_process |
| Synonym | noradrenaline reuptake; levarterenol uptake; norepinephrine import; norepinephrine reuptake |
| Major function | Directed movement of norepinephrine into a cell, typically presynaptic neurons or glial cells |
| Definition source | QuickGO |
| Related molecules | Norepinephrine (3,4-dihydroxyphenyl-2-aminoethanol), a hormone and neurotransmitter |
| Biosynthetic role | Norepinephrine is the biosynthetic precursor of epinephrine |
| Cellular locations | Presynaptic neurons, glial cells, and postsynaptic neurones |
What Is GO:0051620?
GO:0051620 (norepinephrine uptake) is defined by QuickGO as the directed movement of norepinephrine into a cell, typically presynaptic neurons or glial cells. Norepinephrine (3,4-dihydroxyphenyl-2-aminoethanol) is a hormone secreted by the adrenal medulla and a neurotransmitter in the sympathetic peripheral nervous system and in some tracts of the CNS. It is also the biosynthetic precursor of epinephrine. This process includes synonyms such as levarterenol reuptake, levarterenol uptake, noradrenaline reuptake, noradrenaline uptake, norepinephrine import, and norepinephrine reuptake. In essence, it describes the cellular import of norepinephrine from the extracellular space into the intracellular compartment, a key step in regulating its concentration and signaling duration.
Why Is norepinephrine uptake Important in Cell Biology?
Norepinephrine uptake is fundamental to the regulation of norepinephrine signaling in both the central and peripheral nervous systems. By removing norepinephrine from the synaptic cleft, uptake mechanisms terminate its action and allow for precise temporal control of neurotransmission. This process is also critical for recycling norepinephrine and maintaining neurotransmitter stores. Dysregulation of norepinephrine uptake has been linked to psychiatric disorders such as depression, and it is a primary target for antidepressant drugs like noradrenaline reuptake inhibitors. Furthermore, the capacity for uptake in non-neuronal cells, such as postsynaptic neurones, suggests broader roles in modulating tissue responses to norepinephrine. Understanding the molecular players and regulatory mechanisms of norepinephrine uptake is therefore essential for developing therapies for related disorders.
• Regulates synaptic norepinephrine levels and terminates neurotransmission.
• Influences mood and is implicated in depression; target for antidepressant drugs.
• Modulated by pharmacological agents such as halothane, cyclic AMP, soman, and methadone.
• Occurs in both presynaptic and postsynaptic neurones, affecting broader neural circuits.
• Involved in peripheral tissues such as blood vessels and uterus.
• Key for understanding triple uptake inhibitors and their therapeutic potential.
• Essential for norepinephrine recycling and maintenance of neurotransmitter pools.
• Provides a model for studying neurotransmitter transport and drug interactions.
What Happens During norepinephrine uptake?
Recognition and Binding of Norepinephrine
In simple terms: The first step is when norepinephrine outside the cell is recognized and bound by transporter proteins on the cell membrane.
Norepinephrine uptake begins with the recognition of extracellular norepinephrine by specific transporter proteins, such as the norepinephrine transporter (NET). This binding is typically high-affinity and sodium-dependent, although the exact molecular identity may vary by cell type. Studies using rat brain synaptosomes have shown that uptake can be inhibited by compounds like methadone, indicating the involvement of specific transporter systems. In human uterine arteries, uptake is affected by soman, further highlighting the presence of specialized uptake mechanisms. The binding step ensures selectivity for norepinephrine over other catecholamines.
Translocation Across the Plasma Membrane
In simple terms: After binding, the transporter undergoes a conformational change that moves norepinephrine from the outside to the inside of the cell.
Following binding, the transporter undergoes conformational changes that translocate norepinephrine across the plasma membrane into the cytoplasm. This process is energy-dependent and often coupled to ion gradients. In canine saphenous veins, uptake was studied in the presence and absence of halothane, demonstrating that anesthetic agents can modulate this translocation step. Similarly, agents that increase cyclic AMP levels affect uptake and release in rat cerebral cortex slices, suggesting that second messenger pathways regulate the translocation efficiency. The exact kinetics may differ between presynaptic neurons and glial cells.
Intracellular Processing and Storage
In simple terms: Once inside, norepinephrine can be stored in vesicles or metabolized, depending on the cell type.
After entering the cell, norepinephrine is either stored in synaptic vesicles for later release or metabolized by enzymes such as monoamine oxidase (MAO). In uterine nerves of pregnant guinea pigs, uptake and metabolism of [3H]norepinephrine were examined, showing that a portion of the taken-up neurotransmitter is metabolized. In postsynaptic neurones, high-affinity uptake of noradrenaline has been demonstrated, suggesting that these cells can also process norepinephrine. This intracellular handling is crucial for maintaining appropriate neurotransmitter levels and preventing toxicity.
Regulation by Pharmacological and Physiological Factors
In simple terms: The entire uptake process can be sped up or slowed down by drugs, hormones, and cellular signals.
Norepinephrine uptake is subject to regulation by a variety of pharmacological and physiological factors. For example, noradrenaline reuptake inhibition is a key mechanism of action for many antidepressants, and predicting patient response to these inhibitors is an important clinical consideration. Triple uptake inhibitors, which block the reuptake of norepinephrine along with serotonin and dopamine, have shown therapeutic potential in depression and other conditions. Additionally, methadone inhibits serotonin and norepinephrine uptake into rat brain synaptosomes and synaptic vesicles in vitro, but not in vivo, indicating that the in vivo environment may counteract such inhibition. These examples illustrate the complex regulation of norepinephrine uptake.
Key Genes Involved in GO:0051620 norepinephrine uptake
The following genes and proteins are known to be involved in or regulate norepinephrine uptake, based on published literature and their established roles in catecholamine transport and metabolism.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC6A2 (NET) | Primary norepinephrine transporter; mediates high-affinity reuptake | Target for antidepressants; studied in depression and ADHD |
| SLC6A3 (DAT) | Dopamine transporter; can also transport norepinephrine with lower affinity | Involved in reward and motor control; relevant to addiction |
| SLC6A4 (SERT) | Serotonin transporter; primarily serotonin but can influence norepinephrine indirectly | Target for SSRIs; studied in mood disorders |
| MAOA | Metabolizes norepinephrine after uptake | Linked to aggression and mood regulation |
| MAOB | Metabolizes norepinephrine and dopamine | Involved in neurodegeneration and Parkinson's disease |
| COMT | Degrades catecholamines including norepinephrine | Associated with pain sensitivity and psychiatric disorders |
| DBH | Converts dopamine to norepinephrine | Essential for norepinephrine synthesis; marker of noradrenergic neurons |
| TH | Rate-limiting enzyme in catecholamine synthesis | Mutations cause dopa-responsive dystonia |
| ADRA2A | Alpha-2 adrenergic receptor; regulates release and uptake | Target for sedatives and antihypertensives |
| ADRA2B | Alpha-2B adrenergic receptor; modulates norepinephrine release | Involved in vascular tone and stress response |
| ADRB1 | Beta-1 adrenergic receptor; responds to norepinephrine | Target for beta-blockers in cardiovascular disease |
| ADRB2 | Beta-2 adrenergic receptor; responds to norepinephrine | Involved in asthma and smooth muscle relaxation |
| SLC18A2 (VMAT2) | Vesicular monoamine transporter; packages norepinephrine into vesicles | Target for vesicular transport studies and drug action |
| SNAP25 | SNARE protein; involved in vesicle fusion and release | Essential for neurotransmission; studied in neurotoxicity |
| SYN1 | Synapsin I; regulates synaptic vesicle availability | Linked to epilepsy and neurodevelopmental disorders |
| GNAI1 | G protein subunit; coupled to alpha-2 adrenergic receptors | Modulates adenylyl cyclase and neurotransmitter release |
| PRKACA | Protein kinase A; phosphorylates transporters and regulates activity | Involved in cyclic AMP-dependent modulation of uptake |
How Is norepinephrine uptake Regulated?
Norepinephrine uptake is regulated at multiple levels, including transcriptional control of transporter genes, post-translational modifications, and second messenger signaling. Agents that increase cyclic AMP levels have been shown to affect norepinephrine uptake and release in rat cerebral cortex slices, suggesting that cyclic AMP-dependent pathways modulate transporter activity. Additionally, alpha-2 adrenergic receptors can inhibit adenylyl cyclase and reduce cyclic AMP, potentially altering uptake. Pharmacological agents such as halothane, soman, and methadone can also modulate uptake, either directly or indirectly. The presence of high-affinity uptake in postsynaptic neurones indicates that regulation may differ between cell types. Overall, the regulation of norepinephrine uptake is complex and involves both neuronal and non-neuronal elements.
norepinephrine uptake and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLC6A2 (NET) | Depression, ADHD | Knockout mice, overexpression in cell lines |
| SLC6A4 (SERT) | Depression, anxiety | Point mutation knock-in mice |
| MAOA | Aggression, mood disorders | Knockout mice, enzymatic assays |
| COMT | Schizophrenia, pain sensitivity | Knock-in mice with Val158Met polymorphism |
| ADRA2A | Hypertension, sedation | Overexpression in neuronal cultures |
Depression and Mood Disorders
Dysregulation of norepinephrine uptake is strongly implicated in depression. Noradrenaline reuptake inhibition is a well-established mechanism for antidepressant drugs, and predicting which patients will respond to such treatments is a major clinical challenge. Triple uptake inhibitors, which block norepinephrine, serotonin, and dopamine reuptake, have shown efficacy in depression and are being explored for other indications. These findings highlight the importance of norepinephrine uptake in mood regulation and as a therapeutic target.
Cardiovascular and Peripheral Disorders
Norepinephrine uptake in peripheral tissues such as blood vessels and uterus can influence vascular tone and uterine contractility. Studies on canine saphenous veins and human uterine arteries have demonstrated that uptake can be modulated by anesthetics and chemical agents, which may have implications for cardiovascular and obstetric conditions. For example, soman, an organophosphate, affects norepinephrine uptake in human uterine arteries, suggesting potential effects on blood pressure and uterine function.
Neurodegeneration and Neurotoxicity
Alterations in norepinephrine uptake may contribute to neurodegenerative processes. Methadone, an opioid, inhibits norepinephrine uptake in vitro but not in vivo, indicating that the blood-brain barrier and other factors may protect against uptake inhibition. However, chronic exposure to toxins or drugs could impair uptake mechanisms, leading to altered neurotransmitter levels and neurotoxicity. Further research is needed to fully understand these connections.
From norepinephrine uptake-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does SLC6A2 knockout alter norepinephrine clearance? | SLC6A2 knockout mouse |
| How does a point mutation in SLC6A2 affect transporter affinity? | Point mutation knock-in cell line |
| Can overexpression of SLC6A2 increase norepinephrine uptake? | SLC6A2 overexpression in HEK293 cells |
| What is the effect of tagged SLC6A2 on trafficking? | Tagged knock-in (e.g., GFP-SLC6A2) in neurons |
| Does a triple uptake inhibitor affect norepinephrine uptake in vivo? | Wild-type mice treated with inhibitor |
| How does methadone affect uptake in synaptosomes? | Rat brain synaptosome preparation |
How to Study the norepinephrine uptake Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radiolabeled uptake assay | Intracellular accumulation of [3H]norepinephrine | Screening for uptake inhibitors |
| Synaptosome preparation | Uptake into isolated nerve terminals | Studying presynaptic uptake |
| CRISPR knockout | Effect of gene deletion on uptake | Validating SLC6A2 as the main transporter |
| Overexpression | Increased uptake capacity | Assessing transporter efficiency |
| Fluorescent imaging | Real-time uptake dynamics | Visualizing transporter activity in live cells |
| Electrophysiology | Changes in synaptic currents | Linking uptake to neurotransmission |
| Proteomics | Transporter protein levels and modifications | Identifying regulatory post-translational changes |
| RNA-seq | Transcriptional changes in uptake-related genes | Discovering novel regulators |
Radiolabeled Norepinephrine Uptake Assays
The most direct method to measure norepinephrine uptake is to incubate cells or tissue preparations with radiolabeled [3H]norepinephrine and quantify intracellular radioactivity. This approach has been used in canine saphenous veins, rat cerebral cortex slices, and human uterine arteries. It allows for kinetic analysis and pharmacological profiling of uptake inhibitors.
Synaptosome and Vesicle Preparations
Synaptosomes, isolated nerve terminals, are valuable for studying norepinephrine uptake at the presynaptic level. Methadone inhibition of uptake was demonstrated using rat brain synaptosomes and synaptic vesicles. This method provides a more physiological context than cell lines and can distinguish between plasma membrane and vesicular uptake.
Genetic and Pharmacological Manipulation
CRISPR-based knockout or knockdown of candidate genes (e.g., SLC6A2) followed by uptake assays can establish causality. Pharmacological agents such as cyclic AMP analogs, halothane, and soman can be used to probe regulatory pathways. Combining genetic and pharmacological tools provides robust insights into norepinephrine uptake mechanisms.
Imaging and Electrophysiology
Advanced imaging techniques, such as fluorescent false neurotransmitters, can visualize norepinephrine uptake in real time. Electrophysiology can measure the functional consequences of altered uptake on synaptic transmission. These methods complement biochemical assays and provide spatial and temporal resolution.
How CRISPR Can Be Used to Study GO:0051620 norepinephrine uptake
Knockout
CRISPR knockout of SLC6A2 (NET) can completely abolish norepinephrine uptake in cell models, providing definitive evidence for its role. This approach is useful for studying the consequences of loss of function on neurotransmitter levels and downstream signaling. Knockout models can also reveal compensatory mechanisms.
Point Mutation
Introducing point mutations in SLC6A2 that mimic human polymorphisms (e.g., A457P) can help dissect the molecular basis of altered uptake. Such models are valuable for understanding how specific amino acid changes affect transporter affinity, trafficking, or regulation.
Knock-in
Knock-in of tagged versions of SLC6A2 (e.g., GFP or HA tags) allows for real-time tracking of transporter localization and dynamics. This can reveal how norepinephrine uptake is regulated by trafficking and membrane insertion.
Overexpression
Overexpression of SLC6A2 or other transporters in cell lines can increase norepinephrine uptake capacity, enabling studies of transport kinetics and drug efficacy. This approach is particularly useful for high-throughput screening of uptake inhibitors.
How EDITGENE Supports norepinephrine uptake Research
Researchers studying norepinephrine uptake-related genes often need to determine whether a candidate gene is causally involved in the transport process, how specific mutations alter transporter function, or whether overexpression can enhance uptake. EDITGENE provides a comprehensive suite of CRISPR-based services to address these questions, from generating knockout cell lines to creating precise point mutations and knock-in reporters.
Contact EDITGENE today to design your custom CRISPR model for norepinephrine uptake research.
Frequently Asked Questions About norepinephrine uptake
What is norepinephrine uptake?
Norepinephrine uptake (GO:0051620) is the directed movement of norepinephrine into a cell, typically presynaptic neurons or glial cells, as defined by QuickGO.
What genes are involved in norepinephrine uptake?
Key genes include SLC6A2 (NET), SLC6A3 (DAT), SLC6A4 (SERT), MAOA, MAOB, COMT, DBH, TH, and adrenergic receptors such as ADRA2A and ADRB1.
How is norepinephrine uptake regulated?
It is regulated by cyclic AMP signaling, pharmacological agents like halothane and soman, and by transporter gene expression and trafficking.
Why is norepinephrine uptake important in depression?
Noradrenaline reuptake inhibition is a major antidepressant mechanism, and predicting response to these inhibitors is clinically relevant.
Can norepinephrine be taken up by postsynaptic neurons?
Yes, high-affinity uptake of noradrenaline has been demonstrated in postsynaptic neurones.
What methods are used to study norepinephrine uptake?
Common methods include radiolabeled uptake assays, synaptosome preparations, CRISPR knockout, overexpression, and imaging.
What is the role of SLC6A2 in norepinephrine uptake?
SLC6A2 encodes the norepinephrine transporter (NET), which mediates high-affinity reuptake of norepinephrine from the synaptic cleft.
How does methadone affect norepinephrine uptake?
Methadone inhibits serotonin and norepinephrine uptake into rat brain synaptosomes and synaptic vesicles in vitro but not in vivo.
What are triple uptake inhibitors?
Triple uptake inhibitors block the reuptake of serotonin, norepinephrine, and dopamine, and have therapeutic potential in depression and beyond.
How can CRISPR be used to study norepinephrine uptake?
CRISPR can generate knockout, point mutation, knock-in, and overexpression models of genes like SLC6A2 to dissect their roles in uptake.
Conclusion
Norepinephrine uptake (GO:0051620) is a fundamental biological process that controls neurotransmitter availability and signaling. Its dysregulation is linked to depression and other disorders, making it a key target for pharmacological intervention. Research using radiolabeled assays, synaptosomes, and CRISPR models continues to uncover the molecular players and regulatory mechanisms. EDITGENE provides essential tools to accelerate this research through custom gene editing and screening services.
References
- 1. Hunter LW et al.. 1986. Norepinephrine uptake in canine saphenous veins in the presence and absence of halothane.. Anesth Analg 65(4):360-4 PMID: 3954109
- 2. Walker JE et al.. 1978. Uptake and release of norepinephrine by slices of rat cerebral cortex: effect of agents that increase cyclic AMP levels.. Neurology 28(9 Pt 1):900-4 PMID: 211464
- 3. Alm P et al.. 1979. Uptake and metabolism of [3H]norepinephrine in uterine nerves of pregnant guinea pig.. Am J Physiol 236(5):C277-85 PMID: 443367
- 4. Montgomery SA. 1999. Predicting response: noradrenaline reuptake inhibition.. Int Clin Psychopharmacol 14 Suppl 1:S21-6 PMID: 10468325
- 5. Hu CY et al.. 1992. Effects of soman on norepinephrine uptake and electrically stimulated release from human uterine arteries.. Pharmacol Res 25(2):181-5 PMID: 1635895
- 6. Chen Z et al.. 2007. Triple uptake inhibitors: therapeutic potential in depression and beyond.. Expert Opin Investig Drugs 16(9):1365-77 PMID: 17714023
- 7. Slotkin TA et al.. 1978. Methadone inhibits serotonin and norephinephrine uptake into rat brain synaptosomes and synaptic vesicles in vitro but not in vivo.. Eur J Pharmacol 49(4):357-62 PMID: 668807
- 8. al-Damluji S et al.. 1993. High-affinity uptake of noradrenaline in postsynaptic neurones.. Br J Pharmacol 109(2):299-307 PMID: 8358534
